Publication | Open Access

Structure–activity relationships in platelet-activating factor. Part 14: Synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 activity

MedicineImmunologyAntiviral Drug DevelopmentPiperazine DerivativesPlatelet-activating FactorPharmacotherapyStructure–activity RelationshipsAntiviral DrugPharmacologyAntiviral CompoundDrug Discovery